HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Santosh Salunke Selected Research

4- (2,2- dimethyl- 4- phenylbutyrylamino)- N- hydroxybenzamide

9/2010A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Santosh Salunke Research Topics

Disease

2Lung Neoplasms (Lung Cancer)
01/2021 - 09/2010
1Neoplasms (Cancer)
09/2010

Drug/Important Bio-Agent (IBA)

2Histone Deacetylases (Histone Deacetylase)IBA
01/2021 - 09/2010
1benzamideIBA
01/2021
1Dendrimers (Dendrons)IBA
01/2021
14- (2,2- dimethyl- 4- phenylbutyrylamino)- N- hydroxybenzamideIBA
09/2010
1Proteins (Proteins, Gene)FDA Link
09/2010
1Histone Deacetylase InhibitorsIBA
09/2010
1Actins (F Actin)IBA
09/2010
1Histones (Histone)IBA
09/2010

Therapy/Procedure

1Quantum Dots (Quantum Dot)
01/2021